French Court Dismisses Genoway's Lawsuit against Cellectis | GenomeWeb

NEW YORK (GenomeWeb News) – French genome engineering company Cellectis said last week that the Paris Tribunal de Grande Instance has dismissed a lawsuit filed against it by Genoway in January.

The third chamber of the Tribunal de Grande Instance returned a verdict stating, among other things, that a contract between Cellectis and Genoway was terminated on December 30, 2008; that the under-license products detained by Genoway must be destroyed; and that an audit of Genoway's accounts is to be resumed in order for Genoway to pay sums owed to Cellectis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.